These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22496653)

  • 21. A ligand-binding pocket in the dengue virus envelope glycoprotein.
    Modis Y; Ogata S; Clements D; Harrison SC
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):6986-91. PubMed ID: 12759475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry.
    Chin JF; Chu JJ; Ng ML
    Microbes Infect; 2007 Jan; 9(1):1-6. PubMed ID: 17196419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in the identification of dengue virus entry/fusion inhibitors.
    De La Guardia C; Lleonart R
    Biomed Res Int; 2014; 2014():825039. PubMed ID: 25157370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the mode of action of a potent dengue virus capsid inhibitor.
    Scaturro P; Trist IM; Paul D; Kumar A; Acosta EG; Byrd CM; Jordan R; Brancale A; Bartenschlager R
    J Virol; 2014 Oct; 88(19):11540-55. PubMed ID: 25056895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.
    Shankar S; Whitby LR; Casquilho-Gray HE; York J; Boger DL; Nunberg JH
    J Virol; 2016 Aug; 90(15):6799-807. PubMed ID: 27194767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of dengue virus genome induced by a peptide inhibitor.
    Lok SM; Costin JM; Hrobowski YM; Hoffmann AR; Rowe DK; Kukkaro P; Holdaway H; Chipman P; Fontaine KA; Holbrook MR; Garry RF; Kostyuchenko V; Wimley WC; Isern S; Rossmann MG; Michael SF
    PLoS One; 2012; 7(11):e50995. PubMed ID: 23226444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide inhibitors of tembusu virus infection derived from the envelope protein.
    Zhao D; Zhang L; Han K; Liu Q; Yang J; Huang X; Liu Y; Li Y; Zhao P
    Vet Microbiol; 2020 Jun; 245():108708. PubMed ID: 32456819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition.
    Bortz RH; Wong AC; Grodus MG; Recht HS; Pulanco MC; Lasso G; Anthony SJ; Mittler E; Jangra RK; Chandran K
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32611759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein.
    Zhou Z; Khaliq M; Suk JE; Patkar C; Li L; Kuhn RJ; Post CB
    ACS Chem Biol; 2008 Dec; 3(12):765-75. PubMed ID: 19053243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small molecule inhibitors possibly targeting the rearrangement of Zika virus envelope protein.
    Sharma N; Prosser O; Kumar P; Tuplin A; Giri R
    Antiviral Res; 2020 Oct; 182():104876. PubMed ID: 32783901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel flavanone derivative inhibits dengue virus fusion and infectivity.
    Srivarangkul P; Yuttithamnon W; Suroengrit A; Pankaew S; Hengphasatporn K; Rungrotmongkol T; Phuwapraisirisan P; Ruxrungtham K; Boonyasuppayakorn S
    Antiviral Res; 2018 Mar; 151():27-38. PubMed ID: 29360474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendrimers functionalized with membrane-interacting peptides for viral inhibition.
    Tarallo R; Carberry TP; Falanga A; Vitiello M; Galdiero S; Galdiero M; Weck M
    Int J Nanomedicine; 2013; 8():521-34. PubMed ID: 23429490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel dengue virus entry inhibitors via a structure-based approach.
    Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide inhibitors against dengue virus infection.
    Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.
    Tiwari V; Liu J; Valyi-Nagy T; Shukla D
    J Biol Chem; 2011 Jul; 286(28):25406-15. PubMed ID: 21596749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro analysis of synthetic peptides in blocking the entry of dengue virus.
    John AM; Jittmittraphap A; Chattanadee S; Alwin Prem Anand A; Shenbagarathai R; Leaungwutiwong P
    Virus Res; 2019 Jan; 260():142-150. PubMed ID: 30508603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.
    Altmann SE; Jones JC; Schultz-Cherry S; Brandt CR
    Virology; 2009 Jun; 388(2):248-59. PubMed ID: 19395056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assembly.
    de Wispelaere M; Yang PL
    J Virol; 2012 Jul; 86(13):7072-83. PubMed ID: 22532681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III.
    Zu X; Liu Y; Wang S; Jin R; Zhou Z; Liu H; Gong R; Xiao G; Wang W
    Antiviral Res; 2014 Apr; 104():7-14. PubMed ID: 24468276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbohydrate-related inhibitors of dengue virus entry.
    Hidari KI; Abe T; Suzuki T
    Viruses; 2013 Feb; 5(2):605-18. PubMed ID: 23389466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.